R A Biosources Inc

Acurex Biosciences Corporation, located in San Carlos, CA, is dedicated to advancing drug development for neurodegenerative diseases, particularly Parkinson's disease. The company leverages a proprietary platform based on a breakthrough discovery from Stanford University, focusing on identifying druggable targets that can alter disease progression rather than merely treating symptoms. Acurex's lead drug candidate, CU13001, is an oral, brain-penetrant small molecule designed to utilize their innovative approach to treating Parkinson's disease. This therapy is part of a broader pipeline of early-stage neurology drug candidates aimed at achieving significant biomarker changes in neurological diseases. Generated from the website

Gilead Sciences, Inc. is a research-based biopharmaceutical company that specializes in the discovery, development, and commercialization of innovative medicines. The company's primary focus is on advancing healthcare through cutting-edge research and the creation of groundbreaking pharmaceutical solutions. Generated from their website's infomation

Walking Fish Therapeutics, Inc. is a biotech company based in South San Francisco, CA, specializing in the development of cell-based therapeutics for the treatment of serious diseases, with a focus on oncology and regenerative therapies. They have created a powerful B cell platform that harnesses the production capabilities of B cells to deliver multiple potent therapeutic proteins, offering potential applications in various fields such as autoimmune diseases, infectious diseases, deficiency diseases, and cancer treatment. Co-founded and led by Lewis Rusty Williams, an experienced entrepreneur in the biotech industry, Walking Fish Therapeutics has assembled a distinguished team of experts in cell engineering, manufacturing, and clinical research, supported by renowned scientific and strategic advisors. With their deep understanding of B cell biology and critical advances in engineering technologies, Walking Fish is at the forefront of this emerging field, aiming to revolutionize the development of B cell therapies for multiple diseases.Generated from the website